XORTX Therapeutics Inc (NASDAQ:XRTX) currently has a daily average trading volume of 2.88M but it saw 742806 shares traded in last market. With a market cap of 7.08M USD, the company’s current market price of $2.44 came rising about 2.52 while comparing to the previous closing price of $2.38. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.52 and as low as $1.09. In the recent trading on the day, stock has struck highest price mark of $2.08 while lowest mark touched by it was $2.59.
Taking a look at 20-day trading activity of XORTX Therapeutics Inc (XRTX) gives us an average price of $1.63, while its current price level is -67.57% below from 52-week high level whereas it is 123.85% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.71 while that of 200 days or SMA-200 reads an average of $2.56. A closer look into the stock’s movement over the week reveals that its volatility is standing at 48.45% during that period while stretching the period over a month that decreases to 20.87%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.43 which implies that the stock is in neutral territory.
Over the week, XRTX’s stock price is moving 112.17% up while it is 60.53% when we observe its performance for the past one month. Year-to-date it is 5.63% up and over the past year, the stock is showing a downside performance of -64.28%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.34 beat the consensus estimate of -1.8 for the same. The company is expected to be releasing its next quarterly report in October, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, XORTX Therapeutics Inc’s total number of outstanding shares is 2.90M. Company’s return on investment (ROI) stands at -54.83% and return on equity (ROE) at -29.36%. Stock has a price to book (P/B) ratio of 2.62. Its return on asset (ROA) is -23.54% on average.
